• Tidak ada hasil yang ditemukan

alcoholic fatty liver disease (nafld) - UiTM Institutional Repository

N/A
N/A
Protected

Academic year: 2024

Membagikan "alcoholic fatty liver disease (nafld) - UiTM Institutional Repository"

Copied!
5
0
0

Teks penuh

(1)

UNIVERSITI TEKNOLOGI MARA

ASSOCIATION BETWEEN NON- ALCOHOLIC FATTY LIVER

DISEASE (NAFLD) AND

CARDIOVASCULAR DISEASE (CVD) RISK CATEGORIES AMONG PATIENTS ATTENDING UITM

PRIMARY CARE CLINICS

HAYATUL NAJAA BT MIPTAH

MASTERS OF FAMILY MEDICINE

(2)

AUTHOR’S DECLARATION

I declare that the work in this thesis was carried out in accordance with the regulations of Universiti Teknologi MARA. It is original and is the results of my own work, unless otherwise indicated or acknowledged as referenced work. This thesis has not been submitted to any other academic institution or non-academic institution for any degree or qualification.

I, hereby, acknowledge that I have been supplied with the Academic Rules and Regulations for Post Graduate, Universiti Teknologi MARA, regulating the conduct of my study and research.

Name of Student : Hayatul Najaa Miptah Student I.D. No. : 2013987397

Programme : Master of Family Medicine – MD773

Faculty : Medicine

Thesis : Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Disease (CVD) Risk Categories among Adult Patients Attending UiTM Primary Care Clinics

Signature of Student : ………..

Date : March 2019

(3)

ABSTRACT

Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is an emerging novel cardiovascular disease (CVD) risk factor and its prevalence is increasing globally. However, there is paucity in the evidence showing the association between NAFLD and CVD risk in primary care setting. Therefore, the objectives of this study were to determine the prevalence of NAFLD according to CVD risk categories and the factors associated with NAFLD among patients attending UiTM Primary Care Clinic

Method: A cross sectional study was conducted in UiTM Primary Care Clinics.

Patients aged ≥18 years with ³1 risk factor for NAFLD or CVD were recruited using convenience sampling. Participants with history of established liver disease or chronic alcohol use were excluded. Socio-demographics, clinical related data and anthropometric measurements were recorded in a proforma. Blood investigation results were traced from the medical records. Abdominal ultrasound was performed and diagnosis of NAFLD was made using a standardised criteria by a radiologist.. The 10-year CVD risk for each participant was calculated using the general Framingham Risk Score (FRS) calculator for use in primary care. Multiple logistic regression was performed to identify independent associated factors for NAFLD.

Results: A total of 263 participants were recruited. The mean age was 52.3 ± 14.7.

Male and female were equally distributed with 50.2% of the participants were male.

Regarding ethnicity, 79.8% were Malays, 15.2% were Chinese and 7% were Indian/others.. The overall prevalence of NAFLD was 54.4% (95%CI 48%, 60%) and it was higher in males (62.9%, p=0.005). NAFLD was also more prevalent in participants who were employed (60.3%, p=0.023). Regarding FRS category, participants in the high FRS category have higher prevalence of NAFLD (65.5%), followed by those in the moderate category (55.4%) as compared to those in the low category (46.3%), p=0.025. On multiple logistic regression analysis, independent factors associated with NAFLD were being employed (OR=2.44, 95% CI 1.26-4.70, p=0.008) obesity (OR=2.89, 95% CI 1.21-6.91, p=0.017), elevated fasting glucose

³5.6mmol/L (OR=2.79, 95% CI 1.44-5.43, p=0.002), ALT ³34U/L (OR=3.70, 95%

CI 1.85-7.44, p<0.001) and high FRS category (OR=2.82, 95% CI 1.28-6.23, p=0.010).

Conclusion: NAFLD is highly prevalent in UiTM Primary Care Clinics, especially among those in the high FRS category. Patients who were obese, have elevated fasting glucose, elevated ALT and in the high FRS category were more likely to have NAFLD. This study underscores the importance of screening for NAFLD in those with risk factors in primary care. Aggressive intervention must be targeted in those with NAFLD in order to reduce CVD complications and risk of progression.

(4)

ACKNOWLEDGMENT

Alhamdulillah, all praises to Allah for the strength and blessing in completing this thesis. I am so grateful to Him for watching over me during this journey.

Special appreciations to my supervisor, Professor Dr Anis Safura Ramli, for her continuous guidance, support and also for being a great friend and companion throughout this journey. It would not be complete without the guidance by Assoc Prof Dr. Hilwati Hashim and Dr Mariam Mohamad in conducting this study.

My appreciation also goes to all my Primary Care Medicine lecturers and Family Medicine Specialists. Special thanks to my colleagues and friends who have been helping me with this project.

My heartiest appreciation to my family for being the greatest beam of support. To my father; Dato’ Miptah Rohsin who always been believing in me. My mother in law;

Assoc Prof Dr Puteh Saad, who always there to give the motivation when I was down.

I hope to inspire my children; Ameerah, Sakeenah, Irshad and Inshirah, that with patience and perseverance, comes success and gratification. Thank you for surrounding me with your energy so that I would not give up.

I would not have been able to complete this work without the man that made me realise my true potential and taught me the meaning of love for this past 10 years.

Muhammad Izuddin Iliyes, you are truly a great husband.

Finally, this thesis is dedicated to the loving memory of my very dear late mother;

Datin Araznah Mohd Afandi. Thank you for being such an inspiration.

(5)

TABLE OF CONTENT

Page CONFIRMATION BY PANEL OF EXAMINERS iii

AUTHOR’S DECLARATION v

ABSTRACT vi

ACKNOWLEDGMENT vii

TABLE OF CONTENT viii

LIST OF TABLES xi

LIST OF FIGURES xii

LIST OF ABBREVIATIONS xiii

CHAPTER ONE INTRODUCTION 1

1.1 Overview 1

1.2 Problem Statement 3

1.3 Statement of Need 4

1.4 Research Questions 4

1.5 Study Objectives 4

1.6 Research Hypothesis 4

1.7 Significance of the Study 5

CHAPTER TWO LITERATURE REVIEW 6

2.1 Natural History of NAFLD 6

2.2 Prevalence of NAFLD Worldwide and its Associated Factors 12

2.2.1 Prevalence in the West 12

2.2.2 Prevalence of NAFLD in Asia 12

2.2.3 Associated Risk Factors for NAFLD 14

2.3 Association between NAFLD and Cardiovascular Disease (CVD) Events and

Referensi

Dokumen terkait

Nonalcoh olic fatty olic fatty liver disease (NAFLD) liver disease (NAFLD) memiliki karakteristik kerusakan memiliki karakteristik kerusakan hati yang sama dengan

Insulin Resistance and Metabolic Syndrome in Non-Obese Indian Patients With Non- Alcoholic Fatty Liver Disease... AASLD practice guidelines: The Diagnosis and

Keywords: Non-Alcoholic Fatty Liver Disease, Coronary Artery Disease, Ultrasound Date of submission: 11 Dec 2014, Date of acceptance: 16 Dec 2015 Introduction Non-alcoholic fatty

Non- alcoholic fatty liver disease is a spectrum of diseases ranging from non-alcoholic fatty liver NAFL, in which fat accumulates in liver cells with no significant inflammation, to

Although the liver biopsy is the gold standard for identifying NAFLD, it cannot be Correlation between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/51800369 Non-alcoholic fatty liver disease and correlation of serum alanin

Keywords: Meta-analysis; Non-alcoholic fatty liver disease; Hydroxymethylglu- taryl-CoA reductase inhibitors; Ezetimibe Ezetimibe decreased nonalcoholic fatty liver disease activity

In the United States and globally, nonalcoholic fatty liver disease NAFLD is the most common cause of chronic liver disease.1,2By definition, NAFLD occurs in the absence of excessive